Verve Therapeutics
VERV
#6544
Rank
โ‚น45.07 B
Marketcap
โ‚น532.41
Share price
-0.79%
Change (1 day)
-60.16%
Change (1 year)

Operating Margin for Verve Therapeutics (VERV)

Operating Margin as of November 2024 (TTM): -1,074.99%

According to Verve Therapeutics's latest financial reports and stock price the company's current Operating Margin is -1,074.99%. At the end of 2023 the company had an Operating Margin of -1,699.21%.

Operating Margin history for Verve Therapeutics from 2023 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-1,699.21%-79.04%
2022-8,105.82%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.